Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
about
History of clinical transplantationElucidating the metabolic regulation of liver regenerationInsights on augmenter of liver regeneration cloning and functionThe in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functionsAugmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studiesA fresh look at augmenter of liver regeneration in ratsThe unfinished legacy of liver transplantation: emphasis on immunology.Themes of liver transplantation.Cellular transplantation and gene therapy.Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula.Regulation of liver size and regeneration: importance in liver transplantation.The mother lode of liver transplantation, with particular reference to our new journal.Rapid growth of an intact human liver transplanted into a recipient larger than the donor.Evidence for liver cell proliferation during fatal acute liver failureInsulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration.The Eck fistula in animals and humans.The fate of transplanted pancreatic islets in the rat.The effect upon the liver of evisceration with or without hormone replacement.The role of hepatotrophic factors in liver regeneration--a brief review including a preliminary report of the in vitro effects of hepatic regenerative stimulator substance (SS).The effect of splanchnic viscera removal upon canine liver regeneration.Current state of transplantation of the pancreas.Changes in the nuclei of astrocytes following portacaval shunting and portacaval transposition in the rat.Identification of the D1-cell as the source of human pancreatic polypeptide (HPP).Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants.Insulin secretion and carbohydrate metabolism in experimental protein malnutrition.
P2860
Q24596303-21FFDF98-98B8-4957-81D8-E08CBE128F50Q26825034-61DF5349-23DD-46F2-8CFB-F7A5A72FBB16Q28260525-BC73FCE5-A523-4516-850C-38E1DBFD8D04Q28574597-13E1F136-7585-495F-AB80-26128A9C5635Q28575374-AB13088F-237D-4C4E-A61D-7ECF41B69D2DQ28580301-C4D129E5-B8FD-44EC-91DE-8ADF9C435EFEQ30352760-6A11F4B4-22C9-4E0C-88DB-D88BD5CD1C52Q30658256-C1F46504-92A6-4EFA-AC69-8240BF211A7FQ33562515-B8FB388C-0DD7-4EE6-B2A0-DF30F2FE414FQ34236039-6DF8F7D9-BCB7-4332-992E-1C7D0DE1E655Q34289259-D7298047-56F2-478F-A7EC-6D500C26FBBDQ34292268-F1443C5E-DD39-49C5-AA3B-AC18019FE5AEQ34359339-9C74027C-4475-4683-8475-C437C71338C1Q34416080-EABC4055-4203-46E2-ABC6-689CF691F4CDQ34493276-67BE42F7-B437-4112-984B-BCF2A4DD748EQ34546600-AAB49637-67DF-482D-9217-40CD2C68F067Q35160286-D9E42ADB-9F41-43F1-865F-407CEF9D1FC3Q36092721-A101E8C2-4639-4816-9C56-743CE2E2ED35Q37311250-CCC8CCA6-A355-4677-B284-35FC11DC0F10Q39911722-91B2188A-206A-406E-851B-171CAFA587B7Q40168222-7145B777-330D-4466-9AE0-4B9339EB135FQ40864860-2CFC3100-72A9-4B6F-A155-C878AD8080CDQ41043977-43E50D8F-224B-4FF2-B0C1-DCCD0685DB56Q41957007-CA9E1489-D927-406B-B2E1-3AFA7121CC92Q42377833-2CDDCC13-8997-4550-9A4F-9210B0ED48E4Q42398262-2380D978-801A-49DA-9B79-C84AE636A5ABQ51658584-AF903EDD-1DF7-41E8-B07B-BCC87558F784
P2860
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@en
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@nl
type
label
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@en
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@nl
prefLabel
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@en
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@nl
P1433
P1476
Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
@en
P2093
C W Putnam
K A Porter
P304
P356
10.1016/S0140-6736(75)92076-0
P407
P577
1975-12-01T00:00:00Z